Open AccessRandomized Phase 3 Trial of Ruxolitinib for COVID-19–Associated Acute Respiratory Distress Syndrome*
Author(s) -
Lindsay Rein,
Karel Calero,
Ronak J Shah,
Charles I. Ojielo,
Kristin Hudock,
Saba Lodhi,
Farid Sadaka,
Shashi Bellam,
Christopher Palma,
David N. Hager,
Jeannie Daniel,
R Schaub,
Kevin O’Hayer,
Nicole Theodoropoulos
Publication year - 2022
Publication title -
critical care medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.002
H-Index - 271
eISSN - 1530-0293
pISSN - 0090-3493
DOI - 10.1097/ccm.0000000000005682
Subject(s) - medicine , ruxolitinib , placebo , randomized controlled trial , clinical endpoint , concomitant , randomization , mechanical ventilation , pathology , bone marrow , alternative medicine , myelofibrosis